Successful switch from long-term intravenous iloprost to non-invasive combination therapy in idiopathic pulmonary arterial hypertension View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2006-02

AUTHORS

Michael Halank, Martin Kolditz, Christian Opitz, Gert Hoeffken, Ralf Ewert

ABSTRACT

In Europe intravenous (IV) iloprost, an alternative to epoprostenol, is an accepted treatment option for severely compromised patients with idiopathic pulmonary arterial hypertension (IPAH). Once initiated, this therapy usually has to be continued lifelong or as bridging to transplantation. In our paper we describe two patients with IPAH in World Health Organisation (WHO) functional classes II and III while on treatment with continuous IV iloprost monotherapy or combination therapy with continuous IV iloprost plus oral bosentan, respectively. The duration of IV iloprost therapy was 4.5 and 2.5 years, respectively. Because of life-threatening or recurring catheter-related complications during long-term IV iloprost therapy, these patients were switched to non-invasive combination therapy consisting of oral bosentan plus aerosolized iloprost (patient 1) and oral bosentan plus aerosolized iloprost plus oral sildenafil (patient 2), respectively. After four weeks of additional bosentan therapy, stepwise reduction and discontinuation of IV iloprost were performed within eight hours in the patient in WHO class II, and within five days in the patient in WHO class III. Simultaneously, therapy with aerosolized iloprost was started in the first patient and with aerosolized iloprost plus sildenafil in the second patient. Both patients were safely switched from IV iloprost to non-invasive combination therapy while WHO classification of functional status remained unchanged for at least 12 and 14 months, respectively. These data suggest that selected patients with complications due to IV iloprost treatment can be safely switched to non-IV combination therapies. More... »

PAGES

54-59

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00508-005-0507-8

DOI

http://dx.doi.org/10.1007/s00508-005-0507-8

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1028366416

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/16489527


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antihypertensive Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Administration Schedule", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Combinations", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hypertension, Pulmonary", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Iloprost", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Injections, Intravenous", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Patient Selection", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Piperazines", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pulmonary Artery", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Purines", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Sildenafil Citrate", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Sulfonamides", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Sulfones", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Vasodilator Agents", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "name": [
            "Department of Internal Medicine I, Carl Gustav Carus University, Dresden, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Halank", 
        "givenName": "Michael", 
        "id": "sg:person.014150077004.24", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014150077004.24"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Department of Internal Medicine I, Carl Gustav Carus University, Dresden, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kolditz", 
        "givenName": "Martin", 
        "id": "sg:person.01330577317.65", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01330577317.65"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "German Red Cross", 
          "id": "https://www.grid.ac/institutes/grid.433743.4", 
          "name": [
            "Department of Cardiology, DRK-Kliniken Berlin/Westend, Berlin, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Opitz", 
        "givenName": "Christian", 
        "id": "sg:person.0665335343.17", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0665335343.17"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Department of Internal Medicine I, Carl Gustav Carus University, Dresden, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hoeffken", 
        "givenName": "Gert", 
        "id": "sg:person.01360154622.41", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01360154622.41"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Greifswald", 
          "id": "https://www.grid.ac/institutes/grid.5603.0", 
          "name": [
            "Department of Internal Medicine B, Ernst Moritz Arndt University, Greifswald, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ewert", 
        "givenName": "Ralf", 
        "id": "sg:person.01271464135.57", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01271464135.57"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1378/chest.126.3.808", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002341407"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1378/chest.119.1.296", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003434114"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1378/chest.119.1.296", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003434114"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.amjcard.2003.12.031", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003713782"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/hrt.80.2.151", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005075662"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/01.cir.101.20.2388", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007092914"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jacc.2004.02.037", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008422684"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejm199602013340504", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008460952"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/01.cir.0000022687.18568.2a", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018507307"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00508-004-0238-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018568229", 
          "https://doi.org/10.1007/s00508-004-0238-2"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa020204", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024765279"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0735-1097(02)02012-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025129272"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/hrt.79.2.175", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027579681"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1183/09031936.02.02462001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033450214"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1183/09031936.05.00075305", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036977314"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0012-3692(16)48713-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037454394"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1378/chest.124.4.1294", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041254242"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1378/chest.124.4.1294", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041254242"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0195-668x(02)00302-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1054625202"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.7326/0003-4819-107-2-216", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1073692021"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.7326/0003-4819-124-9-199605010-00006", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1073700502"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2006-02", 
    "datePublishedReg": "2006-02-01", 
    "description": "In Europe intravenous (IV) iloprost, an alternative to epoprostenol, is an accepted treatment option for severely compromised patients with idiopathic pulmonary arterial hypertension (IPAH). Once initiated, this therapy usually has to be continued lifelong or as bridging to transplantation. In our paper we describe two patients with IPAH in World Health Organisation (WHO) functional classes II and III while on treatment with continuous IV iloprost monotherapy or combination therapy with continuous IV iloprost plus oral bosentan, respectively. The duration of IV iloprost therapy was 4.5 and 2.5 years, respectively. Because of life-threatening or recurring catheter-related complications during long-term IV iloprost therapy, these patients were switched to non-invasive combination therapy consisting of oral bosentan plus aerosolized iloprost (patient 1) and oral bosentan plus aerosolized iloprost plus oral sildenafil (patient 2), respectively. After four weeks of additional bosentan therapy, stepwise reduction and discontinuation of IV iloprost were performed within eight hours in the patient in WHO class II, and within five days in the patient in WHO class III. Simultaneously, therapy with aerosolized iloprost was started in the first patient and with aerosolized iloprost plus sildenafil in the second patient. Both patients were safely switched from IV iloprost to non-invasive combination therapy while WHO classification of functional status remained unchanged for at least 12 and 14 months, respectively. These data suggest that selected patients with complications due to IV iloprost treatment can be safely switched to non-IV combination therapies.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s00508-005-0507-8", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1070586", 
        "issn": [
          "1026-4906", 
          "1563-2571"
        ], 
        "name": "Wiener klinische Wochenschrift", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1-2", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "118"
      }
    ], 
    "name": "Successful switch from long-term intravenous iloprost to non-invasive combination therapy in idiopathic pulmonary arterial hypertension", 
    "pagination": "54-59", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "8721c904d824f8d9ff18986779df1a4b1f43419870424f9f1aea10fe85dffcf1"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "16489527"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "21620870R"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00508-005-0507-8"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1028366416"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00508-005-0507-8", 
      "https://app.dimensions.ai/details/publication/pub.1028366416"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T01:54", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8700_00000488.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007/s00508-005-0507-8"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00508-005-0507-8'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00508-005-0507-8'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00508-005-0507-8'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00508-005-0507-8'


 

This table displays all metadata directly associated to this object as RDF triples.

236 TRIPLES      21 PREDICATES      66 URIs      39 LITERALS      27 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00508-005-0507-8 schema:about N0f8999a3f43b46df90c52cc6cb2ca236
2 N168d8f892db64be7ae48eeb08f66eb32
3 N17bad5eae6384224bc29af57cbdbeabc
4 N3419967d397d4dea939ecfb4b9487571
5 N358dd3685b7f4012a08ac560adea8b91
6 N3a21d0839e364ea283ca764f9ed2b1e0
7 N491a71e6389f401ea62a204fc1c4e116
8 N60df5eee6b9644859e45f0c8087fb002
9 N92e76c0f4111406ea37ff7bb84c2cefb
10 N93164190d8764d30b332d0bd0c92ba50
11 N9d483035cd3844999d410b459d7391f8
12 Na76f942ada9a4ee5aad6c532e34dc19b
13 Naa45ca2e46c54f808ad23066c1615022
14 Naf8e90e9431f40048869b5e507c4d93f
15 Nd045703850a94028ae1c2a3e6faae044
16 Nd115022ab51c4d4ca09be406158df303
17 Ne6c784af63664194b1e4a77b10f9c80f
18 Nee8641b448df4c2090ab5ca5b4de7c5b
19 anzsrc-for:11
20 anzsrc-for:1103
21 schema:author Nbb673f272bc44269ab823af988aae224
22 schema:citation sg:pub.10.1007/s00508-004-0238-2
23 https://doi.org/10.1016/j.amjcard.2003.12.031
24 https://doi.org/10.1016/j.jacc.2004.02.037
25 https://doi.org/10.1016/s0012-3692(16)48713-1
26 https://doi.org/10.1016/s0195-668x(02)00302-0
27 https://doi.org/10.1016/s0735-1097(02)02012-0
28 https://doi.org/10.1056/nejm199602013340504
29 https://doi.org/10.1056/nejmoa020204
30 https://doi.org/10.1136/hrt.79.2.175
31 https://doi.org/10.1136/hrt.80.2.151
32 https://doi.org/10.1161/01.cir.0000022687.18568.2a
33 https://doi.org/10.1161/01.cir.101.20.2388
34 https://doi.org/10.1183/09031936.02.02462001
35 https://doi.org/10.1183/09031936.05.00075305
36 https://doi.org/10.1378/chest.119.1.296
37 https://doi.org/10.1378/chest.124.4.1294
38 https://doi.org/10.1378/chest.126.3.808
39 https://doi.org/10.7326/0003-4819-107-2-216
40 https://doi.org/10.7326/0003-4819-124-9-199605010-00006
41 schema:datePublished 2006-02
42 schema:datePublishedReg 2006-02-01
43 schema:description In Europe intravenous (IV) iloprost, an alternative to epoprostenol, is an accepted treatment option for severely compromised patients with idiopathic pulmonary arterial hypertension (IPAH). Once initiated, this therapy usually has to be continued lifelong or as bridging to transplantation. In our paper we describe two patients with IPAH in World Health Organisation (WHO) functional classes II and III while on treatment with continuous IV iloprost monotherapy or combination therapy with continuous IV iloprost plus oral bosentan, respectively. The duration of IV iloprost therapy was 4.5 and 2.5 years, respectively. Because of life-threatening or recurring catheter-related complications during long-term IV iloprost therapy, these patients were switched to non-invasive combination therapy consisting of oral bosentan plus aerosolized iloprost (patient 1) and oral bosentan plus aerosolized iloprost plus oral sildenafil (patient 2), respectively. After four weeks of additional bosentan therapy, stepwise reduction and discontinuation of IV iloprost were performed within eight hours in the patient in WHO class II, and within five days in the patient in WHO class III. Simultaneously, therapy with aerosolized iloprost was started in the first patient and with aerosolized iloprost plus sildenafil in the second patient. Both patients were safely switched from IV iloprost to non-invasive combination therapy while WHO classification of functional status remained unchanged for at least 12 and 14 months, respectively. These data suggest that selected patients with complications due to IV iloprost treatment can be safely switched to non-IV combination therapies.
44 schema:genre research_article
45 schema:inLanguage en
46 schema:isAccessibleForFree false
47 schema:isPartOf N0f9e6dfd20304bbb9474cd29f25a144d
48 N8f6ac57e30c24b61ba0898b725650a87
49 sg:journal.1070586
50 schema:name Successful switch from long-term intravenous iloprost to non-invasive combination therapy in idiopathic pulmonary arterial hypertension
51 schema:pagination 54-59
52 schema:productId N47e43a595b5f4f7088ea5318945c708e
53 N526a4e787b6e4561a698ad0274d19f45
54 N7bdd4df269ff4fff845e0859207a6837
55 N818d00e6a27240cd9a10892660ed8b68
56 Nf9c79275924a423da7856cd52b49e5e9
57 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028366416
58 https://doi.org/10.1007/s00508-005-0507-8
59 schema:sdDatePublished 2019-04-11T01:54
60 schema:sdLicense https://scigraph.springernature.com/explorer/license/
61 schema:sdPublisher N7811ea678aa541fe8e4560f529faf76e
62 schema:url http://link.springer.com/10.1007/s00508-005-0507-8
63 sgo:license sg:explorer/license/
64 sgo:sdDataset articles
65 rdf:type schema:ScholarlyArticle
66 N0f8999a3f43b46df90c52cc6cb2ca236 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
67 schema:name Female
68 rdf:type schema:DefinedTerm
69 N0f9e6dfd20304bbb9474cd29f25a144d schema:volumeNumber 118
70 rdf:type schema:PublicationVolume
71 N168d8f892db64be7ae48eeb08f66eb32 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
72 schema:name Sulfones
73 rdf:type schema:DefinedTerm
74 N17bad5eae6384224bc29af57cbdbeabc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
75 schema:name Drug Combinations
76 rdf:type schema:DefinedTerm
77 N3419967d397d4dea939ecfb4b9487571 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
78 schema:name Vasodilator Agents
79 rdf:type schema:DefinedTerm
80 N358dd3685b7f4012a08ac560adea8b91 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
81 schema:name Middle Aged
82 rdf:type schema:DefinedTerm
83 N3a21d0839e364ea283ca764f9ed2b1e0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
84 schema:name Drug Administration Schedule
85 rdf:type schema:DefinedTerm
86 N47e43a595b5f4f7088ea5318945c708e schema:name readcube_id
87 schema:value 8721c904d824f8d9ff18986779df1a4b1f43419870424f9f1aea10fe85dffcf1
88 rdf:type schema:PropertyValue
89 N491a71e6389f401ea62a204fc1c4e116 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
90 schema:name Iloprost
91 rdf:type schema:DefinedTerm
92 N4b2dba6610624e61aa33f0f4c293b53e rdf:first sg:person.01271464135.57
93 rdf:rest rdf:nil
94 N526a4e787b6e4561a698ad0274d19f45 schema:name nlm_unique_id
95 schema:value 21620870R
96 rdf:type schema:PropertyValue
97 N60df5eee6b9644859e45f0c8087fb002 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
98 schema:name Pulmonary Artery
99 rdf:type schema:DefinedTerm
100 N7811ea678aa541fe8e4560f529faf76e schema:name Springer Nature - SN SciGraph project
101 rdf:type schema:Organization
102 N7bdd4df269ff4fff845e0859207a6837 schema:name dimensions_id
103 schema:value pub.1028366416
104 rdf:type schema:PropertyValue
105 N818d00e6a27240cd9a10892660ed8b68 schema:name doi
106 schema:value 10.1007/s00508-005-0507-8
107 rdf:type schema:PropertyValue
108 N8f6ac57e30c24b61ba0898b725650a87 schema:issueNumber 1-2
109 rdf:type schema:PublicationIssue
110 N92e76c0f4111406ea37ff7bb84c2cefb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
111 schema:name Purines
112 rdf:type schema:DefinedTerm
113 N93164190d8764d30b332d0bd0c92ba50 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
114 schema:name Patient Selection
115 rdf:type schema:DefinedTerm
116 N9d483035cd3844999d410b459d7391f8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
117 schema:name Sulfonamides
118 rdf:type schema:DefinedTerm
119 Na76f942ada9a4ee5aad6c532e34dc19b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Injections, Intravenous
121 rdf:type schema:DefinedTerm
122 Naa45ca2e46c54f808ad23066c1615022 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
123 schema:name Hypertension, Pulmonary
124 rdf:type schema:DefinedTerm
125 Nac6a3c907bf84c74b966c1a11a7b8d4f rdf:first sg:person.01330577317.65
126 rdf:rest Nc326175ebf064b6ab5f5ce3827c6e448
127 Naf8e90e9431f40048869b5e507c4d93f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Humans
129 rdf:type schema:DefinedTerm
130 Nbb673f272bc44269ab823af988aae224 rdf:first sg:person.014150077004.24
131 rdf:rest Nac6a3c907bf84c74b966c1a11a7b8d4f
132 Nc326175ebf064b6ab5f5ce3827c6e448 rdf:first sg:person.0665335343.17
133 rdf:rest Nd45bd7c679494381b1909a17d2503128
134 Nd045703850a94028ae1c2a3e6faae044 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
135 schema:name Piperazines
136 rdf:type schema:DefinedTerm
137 Nd115022ab51c4d4ca09be406158df303 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Treatment Outcome
139 rdf:type schema:DefinedTerm
140 Nd45bd7c679494381b1909a17d2503128 rdf:first sg:person.01360154622.41
141 rdf:rest N4b2dba6610624e61aa33f0f4c293b53e
142 Ne6408a4820d54e30860ca0f85018d356 schema:name Department of Internal Medicine I, Carl Gustav Carus University, Dresden, Germany
143 rdf:type schema:Organization
144 Ne6c784af63664194b1e4a77b10f9c80f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
145 schema:name Sildenafil Citrate
146 rdf:type schema:DefinedTerm
147 Nee8641b448df4c2090ab5ca5b4de7c5b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name Antihypertensive Agents
149 rdf:type schema:DefinedTerm
150 Nf7c6acc9587a4140a8a8307190d3ba66 schema:name Department of Internal Medicine I, Carl Gustav Carus University, Dresden, Germany
151 rdf:type schema:Organization
152 Nf7ef368541634c68b3aef42f08ae6f69 schema:name Department of Internal Medicine I, Carl Gustav Carus University, Dresden, Germany
153 rdf:type schema:Organization
154 Nf9c79275924a423da7856cd52b49e5e9 schema:name pubmed_id
155 schema:value 16489527
156 rdf:type schema:PropertyValue
157 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
158 schema:name Medical and Health Sciences
159 rdf:type schema:DefinedTerm
160 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
161 schema:name Clinical Sciences
162 rdf:type schema:DefinedTerm
163 sg:journal.1070586 schema:issn 1026-4906
164 1563-2571
165 schema:name Wiener klinische Wochenschrift
166 rdf:type schema:Periodical
167 sg:person.01271464135.57 schema:affiliation https://www.grid.ac/institutes/grid.5603.0
168 schema:familyName Ewert
169 schema:givenName Ralf
170 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01271464135.57
171 rdf:type schema:Person
172 sg:person.01330577317.65 schema:affiliation Nf7c6acc9587a4140a8a8307190d3ba66
173 schema:familyName Kolditz
174 schema:givenName Martin
175 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01330577317.65
176 rdf:type schema:Person
177 sg:person.01360154622.41 schema:affiliation Ne6408a4820d54e30860ca0f85018d356
178 schema:familyName Hoeffken
179 schema:givenName Gert
180 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01360154622.41
181 rdf:type schema:Person
182 sg:person.014150077004.24 schema:affiliation Nf7ef368541634c68b3aef42f08ae6f69
183 schema:familyName Halank
184 schema:givenName Michael
185 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014150077004.24
186 rdf:type schema:Person
187 sg:person.0665335343.17 schema:affiliation https://www.grid.ac/institutes/grid.433743.4
188 schema:familyName Opitz
189 schema:givenName Christian
190 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0665335343.17
191 rdf:type schema:Person
192 sg:pub.10.1007/s00508-004-0238-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018568229
193 https://doi.org/10.1007/s00508-004-0238-2
194 rdf:type schema:CreativeWork
195 https://doi.org/10.1016/j.amjcard.2003.12.031 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003713782
196 rdf:type schema:CreativeWork
197 https://doi.org/10.1016/j.jacc.2004.02.037 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008422684
198 rdf:type schema:CreativeWork
199 https://doi.org/10.1016/s0012-3692(16)48713-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037454394
200 rdf:type schema:CreativeWork
201 https://doi.org/10.1016/s0195-668x(02)00302-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1054625202
202 rdf:type schema:CreativeWork
203 https://doi.org/10.1016/s0735-1097(02)02012-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025129272
204 rdf:type schema:CreativeWork
205 https://doi.org/10.1056/nejm199602013340504 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008460952
206 rdf:type schema:CreativeWork
207 https://doi.org/10.1056/nejmoa020204 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024765279
208 rdf:type schema:CreativeWork
209 https://doi.org/10.1136/hrt.79.2.175 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027579681
210 rdf:type schema:CreativeWork
211 https://doi.org/10.1136/hrt.80.2.151 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005075662
212 rdf:type schema:CreativeWork
213 https://doi.org/10.1161/01.cir.0000022687.18568.2a schema:sameAs https://app.dimensions.ai/details/publication/pub.1018507307
214 rdf:type schema:CreativeWork
215 https://doi.org/10.1161/01.cir.101.20.2388 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007092914
216 rdf:type schema:CreativeWork
217 https://doi.org/10.1183/09031936.02.02462001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033450214
218 rdf:type schema:CreativeWork
219 https://doi.org/10.1183/09031936.05.00075305 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036977314
220 rdf:type schema:CreativeWork
221 https://doi.org/10.1378/chest.119.1.296 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003434114
222 rdf:type schema:CreativeWork
223 https://doi.org/10.1378/chest.124.4.1294 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041254242
224 rdf:type schema:CreativeWork
225 https://doi.org/10.1378/chest.126.3.808 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002341407
226 rdf:type schema:CreativeWork
227 https://doi.org/10.7326/0003-4819-107-2-216 schema:sameAs https://app.dimensions.ai/details/publication/pub.1073692021
228 rdf:type schema:CreativeWork
229 https://doi.org/10.7326/0003-4819-124-9-199605010-00006 schema:sameAs https://app.dimensions.ai/details/publication/pub.1073700502
230 rdf:type schema:CreativeWork
231 https://www.grid.ac/institutes/grid.433743.4 schema:alternateName German Red Cross
232 schema:name Department of Cardiology, DRK-Kliniken Berlin/Westend, Berlin, Germany
233 rdf:type schema:Organization
234 https://www.grid.ac/institutes/grid.5603.0 schema:alternateName University of Greifswald
235 schema:name Department of Internal Medicine B, Ernst Moritz Arndt University, Greifswald, Germany
236 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...